Literature DB >> 21707339

Determinants of tubal ligation in Puebla, Mexico.

Alanna E F Rudzik1, Susan H Leonard, Lynnette L Sievert.   

Abstract

Tubal ligation provides an effective and reliable method by which women can choose to limit the number of children they will bear. However, because of the irreversibility of the procedure and other potential disadvantages, it is important to understand factors associated with women's choice of this method of birth control. Between May 1999 and August 2000, data were collected from 755 women aged 40 to 60 years from a cross-section of neighborhoods of varying socio-economic make-up in Puebla, Mexico, finding a tubal ligation rate of 42.2%. Multiple logistic regression models were utilized to examine demographic, socio-economic, and reproductive history characteristics in relation to women's choice of tubal ligation. Regression analyses were repeated with participants grouped by age to determine how the timing of availability of tubal ligation related to the decision to undergo the procedure. The results of this study suggest that younger age, more education, use of some forms of birth control, and increased parity were associated with women's decisions to undergo tubal ligation. The statistically significant difference of greater tubal ligation and lower hysterectomy rates across age groups reflect increased access to tubal ligation in Mexico from the early 1970s, supporting the idea that women's choice of tubal ligation was related to access.

Entities:  

Mesh:

Year:  2011        PMID: 21707339     DOI: 10.1080/03630242.2011.574793

Source DB:  PubMed          Journal:  Women Health        ISSN: 0363-0242


  2 in total

1.  Exploring knowledge, belief and experiences in sexual and reproductive health in immigrant Hispanic women.

Authors:  Ana M Quelopana; Cristina Alcalde
Journal:  J Immigr Minor Health       Date:  2014-10

2.  The Rise and Fall of Female Sterilization in Jos, Nigeria: A Cause for Concern.

Authors:  Makshwar L Kahansim; Victor C Pam; Josiah T Mutihir
Journal:  Niger Med J       Date:  2020-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.